Advertisement

Advertisement

Most Read Stories
2019 GI Cancers Symposium: Neoadjuvant Chemotherapy vs Upfront Surgery in Resectable Pancreatic Cancer
2019 GI Cancers Symposium: Pembrolizumab in Second-Line Therapy for Advanced Esophageal Cancer
Is There a Benefit to Adding Rituximab to Methotrexate-Based Chemotherapy in Primary CNS Lymphoma?
2019 GI Cancers Symposium: Addition of Andecaliximab to mFOLFOX6 in Treatment-Naive Advanced Gastric or GEJ Adenocarcinoma
2019 GI Cancers Symposium: Durvalumab, Tremelimumab, and Best Supportive Care vs Best Supportive Care Alone in Advanced, Refractory Colorectal Cancer
2019 GI Cancers Symposium: Nivolumab vs Nivolumab Plus Ipilimumab in Resectable Hepatocellular Carcinoma
2019 GI Cancers Symposium: Safety, Efficacy of Trifluridine/Tipiracil in Metastatic Gastric Cancer With or Without Gastrectomy
Updated Survival Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy in Previously Untreated, Advanced NSCLC
FDA Approves Cabozantinib for Previously Treated Hepatocellular Carcinoma
Response to Induction Chemotherapy and Outcomes With Definitive Chemoradiotherapy or Surgery in Sinonasal Undifferentiated Carcinoma
SABCS 2018: KATHERINE Trial: Adjuvant Ado-Trastuzumab Emtansine vs Trastuzumab in Early-Stage HER2-Positive Breast Cancer
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
Study Finds High Tumor Mutational Load Is a Predictor of Response to Immunotherapy in Some Cancers
OlympiAD Trial: Olaparib in Metastatic Breast Cancer With Germline BRCA Mutation
SABCS 2018: Delayed Initiation of Adjuvant Chemotherapy Associated With Worse Outcomes in Patients With Triple-Negative Breast Cancer
Germline DNA Repair Mutations and Outcomes in Metastatic Castration-Resistant Prostate Cancer
Al Identifies Features of Tumor Cells in High-Risk Ovarian Cancer  
VISTA Checkpoint Implicated in Pancreatic Cancer Immunotherapy Resistance
Comorbidities and Cancer Clinical Trial Enrollment
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?

Advertisement

Advertisement



;
Advertisement